Calgary-based Attabotics to receive $34 million from federal government
Calgary-based robotics startup Attabotics is set to receive an investment of $34 million from the federal government through a contribution from the Strategic Innovation Fund.
The announcement is set to be made Tuesday morning. The Strategic Innovation Fund financing is for a $73.3 million project Attabotics is working on.
“We look forward to using these funds to further grow our business and create even more opportunities for the local economy.”
Founded in 2015, Attabotics will use the funds to further develop and bring to market its robotics warehouse technologies. Through the project the startup has agreed to maintain a minimum of 165 employees a year and create 449 new jobs by 2031. Attabotics has also committed to investing hundreds of millions in R&D by 2038.
Press release content from PR Newswire. The AP news staff was not involved in its creation.
ImmunoPrecise Collaboration Enables Preclinical Manufacturing of Lead Antibodies Targeting SARS-CoV-2
December 11, 2020 GMT
VICTORIA, BC, Dec. 11, 2020 /PRNewswire/ - IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSXV: IPA) (OTCQB: IPATD) (FSE: TQB2), a leader in full-service, therapeutic antibody discovery and development, today announced that it has entered into a research collaboration with the National Research Council of Canada’s (NRC) Human Health Therapeutics (HHT) Research Centre to develop its neutralizing PolyTope™ antibodies against SARS-CoV-2.
IPA is also considering acquiring a license for the NRC CHO cell-based rapid expression platform to be used in pre-clinical and clinical manufacturing of their lead monoclonal antibodies. Researchers from the NRC’s HHT Research Centre will deploy the CHO-based expression platform to accelerate the identification an